VACCINE
Clinical trials for VACCINE explained in plain language.
Never miss a new study
Get alerted when new VACCINE trials appear
Sign up with your email to follow new studies for VACCINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine study targets sneaky pneumonia bacteria
⭐️ VACCINE ⭐️ Recruiting nowThis study tests whether two different pneumococcal vaccines can create antibodies that kill newly discovered types of pneumonia bacteria. Researchers will give healthy adults one of the vaccines and measure how well their immune system fights these bacteria. The goal is to see i…
Matched conditions: VACCINE
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a personalized vaccine created from a patient's own immune cells (dendritic cells) that are trained to attack unique markers on their tumor. It is for people with advanced solid tumors who have not responded to standard treatments. The main goal is to check safet…
Matched conditions: VACCINE
Phase: NA • Sponsor: Fudan University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:04 UTC
-
Friends helping friends: new study aims to boost COVID-19 vaccination in latino communities
⭐️ VACCINE ⭐️ Recruiting nowThis study tests two ways to encourage COVID-19 vaccination among Latino adults and their friends in Maryland. One group learns motivational interviewing skills to talk about vaccines, while the other just gets vaccine information. Researchers will compare how many friends get va…
Matched conditions: VACCINE
Phase: NA • Sponsor: Johns Hopkins University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:57 UTC
-
Which pneumonia vaccine works best for lymphoma patients? new study aims to find out
Disease control Recruiting nowThis study compares two pneumococcal vaccination strategies in 160 adults with lymphoma who have had chemotherapy. One group gets two vaccines (Prevenar 13 followed by Pneumovax 23), while the other gets a single newer vaccine (Prevenar 20). Researchers will measure immune respon…
Matched conditions: VACCINE
Phase: PHASE4 • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC